Genflow Biosciences plc (LON:GENF – Get Free Report) shares were up 8.1% on Friday . The company traded as high as GBX 2 and last traded at GBX 2. Approximately 1,475,586 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 4,868,584 shares. The stock had previously closed at GBX 1.85.
Genflow Biosciences Stock Up 8.1%
The firm has a fifty day simple moving average of GBX 1.87 and a 200-day simple moving average of GBX 1.32. The company has a market cap of £9.87 million, a PE ratio of -3.98 and a beta of 2.37.
Genflow Biosciences (LON:GENF – Get Free Report) last posted its earnings results on Tuesday, September 30th. The company reported GBX (0.19) earnings per share for the quarter. Genflow Biosciences had a net margin of 778.46% and a negative return on equity of 208.12%.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Recommended Stories
- Five stocks we like better than Genflow Biosciences
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
